Rhythm Pharmaceuticals In... (RYTM)
54.01
0.07 (0.13%)
At close: Jan 15, 2025, 10:52 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 77.43M | 23.64M | 3.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 9.30M | 2.13M | 599.00K | 690.00K | 834.00K | 442.00K | 223.00K | 144.00K | n/a | n/a | n/a | n/a |
| Gross Profit | 68.13M | 21.50M | 2.56M | -690.00K | -834.00K | -442.00K | -223.00K | -144.00K | n/a | n/a | n/a | n/a |
| Operating Income | -184.36M | -179.16M | -170.06M | -136.57M | -146.00M | -78.42M | -32.41M | -25.91M | -10.57M | -6.49M | -21.45M | -18.14M |
| Interest Income | 13.95M | 4.03M | 447.00K | 2.58M | 5.27M | 4.35M | 566.00K | 33.00K | n/a | n/a | n/a | n/a |
| Pretax Income | -184.11M | -181.12M | -69.61M | -134.00M | -140.73M | -74.06M | -33.71M | -25.87M | -11.07M | -6.49M | -21.43M | -18.13M |
| Net Income | -184.68M | -183.08M | -68.01M | -130.73M | -134.62M | -74.06M | -33.71M | -25.87M | -11.07M | -6.49M | -21.43M | -18.13M |
| Selling & General & Admin | 117.53M | 92.03M | 68.49M | 46.13M | 36.55M | 28.08M | 9.52M | 6.31M | 3.42M | 1.21M | 3.43M | 2.46M |
| Research & Development | 134.95M | 108.63M | 104.13M | 90.45M | 109.45M | 50.34M | 22.89M | 19.59M | 7.15M | 5.28M | 18.02M | 15.68M |
| Other Expenses | n/a | -790.00K | 100.00M | n/a | n/a | n/a | -1.86M | n/a | -500.00K | n/a | n/a | n/a |
| Operating Expenses | 252.48M | 200.66M | 172.61M | 136.57M | 146.00M | 78.42M | 32.41M | 25.91M | 10.57M | 6.49M | 21.45M | 18.14M |
| Interest Expense | 13.89M | 5.20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 261.79M | 202.79M | 173.21M | 136.57M | 146.00M | 78.42M | 32.41M | 25.91M | 10.57M | 6.49M | 21.45M | 18.14M |
| Income Tax | 564.00K | 1.96M | -1.60M | -3.27M | -6.11M | 4.35M | 1.07M | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 57.67M | 52.12M | 49.60M | 44.13M | 36.42M | 31.00M | 13.27M | 16.73M | 16.73M | 10.20M | 50.27M | 50.27M |
| Shares Outstanding (Diluted) | 57.67M | 52.12M | 49.60M | 44.13M | 36.42M | 31.00M | 13.27M | 16.73M | 16.73M | 10.20M | 50.27M | 50.27M |
| EPS (Basic) | -3.2 | -3.51 | -1.37 | -2.96 | -3.7 | -2.39 | -2.54 | -1.55 | -0.66 | -0.64 | -0.43 | -0.36 |
| EPS (Diluted) | -3.2 | -3.51 | -1.37 | -2.96 | -3.7 | -2.39 | -2.54 | -1.55 | -0.66 | -0.64 | -0.43 | -0.36 |
| EBITDA | -168.46M | -174.51M | -68.45M | -135.88M | -145.17M | -77.97M | -32.19M | -25.76M | -10.07M | n/a | -21.41M | -18.12M |
| Depreciation & Amortization | 1.76M | 1.40M | 1.16M | 690.00K | 834.00K | 442.00K | 223.00K | 144.00K | 500.00K | 6.49M | 20.00K | 17.00K |